Otitis media: a preventable disease? Proceedings of an International Symposium organized by the Marcel Mérieux Foundation, Veyrier-du-Lac, France, February 13 to 16, 2000

This publication has 44 references indexed in Scilit:

• Cell biology of tubotympanum in relation to pathogenesis of otitis media — a review
  Vaccine, 2000
• Immunization of Mice with Combinations of Pneumococcal Virulence Proteins Elicits Enhanced Protection against Challenge with Streptococcus pneumoniae
  Infection and Immunity, 2000
• Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
  The Pediatric Infectious Disease Journal, 2000
• Intranasal Immunization of Mice with a Mixture of the Pneumococcal Proteins PsaA and PspA Is Highly Protective against Nasopharyngeal Carriage ofStreptococcus pneumoniae
  Infection and Immunity, 2000
• Immunogenicity and Impact on Nasopharyngeal Carriage of a Nonavalent Pneumococcal Conjugate Vaccine
  The Journal of Infectious Diseases, 1999
• Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants
  Pediatrics, 1998
• Respiratory syncytial virus–enriched globulin for the prevention of acute otitis media in high-risk children
  The Journal of Pediatrics, 1996
• Administration of intravenous immunoglobulins for prophylaxis or treatment of infection in preterm infants: meta-analyses.
  Archives of Disease in Childhood: Fetal & Neonatal, 1995
• Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children
  New England Journal of Medicine, 1993
• Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children
  The Journal of Pediatrics, 1993